The Bureau of Internal Revenue (BIR), in coordination with the Food and Drug Administration (FDA), has made 2,277 medicines VAT-exempt, covering treatments for cancer, diabetes, hypertension, and kidney disease, with the list continuing to grow as more drugs are endorsed for exemption, BIR Commissioner Charlito Mendoza said Saturday. Mendoza made the disclosure in an interview on DZRH News program Special on Saturday…
